Abstract:Introduction MASLD is a multifactorial disease for which there are no approved pharmacological therapies and for which lifestyle changes still represent the most effective remedy. Nutritional studies could be essential to increase knowledge and assess causality in the field of MASLD. Aim Our aim is to monitor patients diagnosed with MASLD who attend a weight-loss program at our Hepatology Unit, through repeated measurements of clinical parameters, transient elastography (TE), controlled attenuation parameter (CAP), and blood tests. The interaction between genetics and TE/CAP is also considered. Patients and Methods Overweight or obese MASLD patients, aged ≥ 18, without decompensated cirrhosis or active cancer, were proposed to start a low-glycemic index, nutritionist-guided diet. Weight, BMI, TE/CAP, and blood tests recorded at baseline were compared with the same measurements obtained after 6 months. Weight loss was categorized into classes of weight change compared to baseline (<5%, 5%–10%, >10%). A genetic risk score (GRS) was calculated for each patient and related to changes in TE/CAP Results Among the 131 patients who underwent the first nutritional visit, 50 attended the 6-months control visit to date. At this time-point, as we previously observed in earlier follow-up visits, a significant difference compared to baseline was found in weight, BMI, and CAP (respectively -7.47 kg [-8.10%], -2.67 Kg/m2, and -45.88 dB/m; all p<0.0001). The latter improved proportionally to the extent of weight loss; mean liver stiffness, on the contrary, remained almost unchanged, but it decreased in the >10% weight reduction class. Patients with high GRS experienced a greater decrease in TE/CAP values after 6 months of diet. Liver biochemistry also improved. Conclusions Diet-induced weight loss has beneficial effects on MASLD, and liver disease improves proportionally to its extent. Genetics appear to modulate change in liver disease severity in patients on diet. Weight loss data represent the backbone of our ongoing studies on changes in metabolomics and gut microbiota for these patients, aimed at further investigate the pathophysiology of the disease.

The glucokinase regulator gene (GCKR) rs780094 C>T single nucleotide polymorphism affect diet response in overweight/obese subjects with metabolic-dysfunction associated steatotic liver disease

Response to a 6-month personalized dietary intervention in patients with metabolic dysfunction-associated steatotic liver disease

Glucokinase Regulatory Protein (GCKR) Gene rs4425043 Polymorphism is Associated with Overweight and Obesity in Chinese Women

Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD

Impaired GK-GKRP interaction rather than direct GK activation worsens lipid profiles and contributes to long-term complications: a Mendelian randomization study

Polyunsaturated Fatty Acids Modulate the Association Between PIK3CA-KCNMB3 Genetic Variants and Insulin Resistance

Glucokinase regulatory protein rs780094 polymorphism is associated with type 2 diabetes mellitus, dyslipidemia, non-alcoholic fatty liver disease, and nephropathy

Compromised chronic efficacy of a Glucokinase Activator AZD1656 in mouse models for common human GCKR variants

Genetic Variants at PSMD3 Interact with Dietary Fat and Carbohydrate to Modulate Insulin Resistance

Genetic Evidence for GLP‐1 and GIP Receptors as Targets for Treatment and Prevention of MASLD/MASH

Association Between Rs780094 Polymorphism in GCKR and Plasma Lipid Levels in Children and Adolescents

Associations of common polymorphisms in GCKR with type 2 diabetes and related traits in a Han Chinese population: a case-control study

Genetic Variation in the GCKR Gene is Associated with Non-Alcoholic Fatty Liver Disease in Chinese People

Epidemiological Study on the Interaction between the PNPLA3 (rs738409) and Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease

Repeated measurements and data integration to monitor and study MASLD patients experiencing weight loss

Discrete Associations of the GCKR Variant with Metabolic Risk in a Chinese Population: Longitudinal Change Analysis

Potential causal links between genetic variants in SAMM50, SUGP1, MAU2, and GATAD2A and liver fat in individuals with normal weight

Sex-specific impact of GCKR rs1260326 polymorphism on metabolic traits in an older Japanese population: the Bunkyo Health Study

SGCG rs679482 Associates With Weight Loss Success in Response to an Intensively Supervised Outpatient Program

Genetic Variants in CD36 Involved in Fat Taste Perception: Association with Anthropometric and Clinical Parameters in Overweight and Obese Subjects Affected by Type 2 Diabetes or Dysglycemia—A Pilot Study

Association of glucokinase gene and glucokinase regulatory protein gene polymorphisms with gestational diabetes mellitus: A case–control study